C.1 Raw Data

This section present the raw data collected during the sessions with the subjects. The data is summarized in three tables, one for each treament (0 delay, 0.250 s delay, and 0.500s delay). All timing information is given in seconds, unless otherwise specified.

Each row corresponds to one subject for the given treament. Column Q1 to Q10 (see section Procedures and Problems) represent the time to answer the question, and #hplnks column represents the number of traversed hyperlink to complete the experiment.

Raw Data for Treatment I (animation speed = 0.000 seconds)

 

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

# hplnks

Subject 1

18.419

29.724

19.232

23.100

13.304

11.904

42.332

14.098

14.318

15.318

49

Subject 2

15.836

28.107

14.740

19.521

20.227

13.812

59.417

20.133

14.286

20.347

55

Subject 3

16.987

32.766

31.470

14.839

14.077

12.176

23.768

24.066

13.770

17.779

39

Subject 4

18.185

24.185

15.986

17.707

7.059

21.793

15.544

30.517

14.265

16.869

35

Subject 5

32.207

27.854

24.018

26.044

18.675

25.544

30.598

27.973

15.151

26.611

39

Subject 6

15.489

14.951

15.406

19.064

27.069

10.382

13.966

21.869

27.905

20.699

41

Subject 7

21.641

37.307

16.130

15.857

16.012

19.018

24.765

30.075

18.344

19.182

39

Subject 8

10.970

16.832

19.605

17.037

16.634

11.586

11.512

38.015

15.019

24.705

38

Subject 9

34.963

59.261

22.819

21.648

25.993

13.268

17.210

20.721

12.856

16.873

69

Subject 10

16.628

31.415

14.439

18.357

14.740

11.940

16.722

18.338

14.158

15.360

39

Raw Data for Treatment II (animation speed = 0.250 seconds)

 

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

# hplnks

Subject 1

29.811

20.517

14.701

17.542

14.321

12.753

15.214

18.113

16.412

19.377

37

Subject 2

29.542

91.745

19.378

29.26

24.078

14.347

18.351

27.347

15.412

29.938

48

Subject 3

11.524

12.817

15.255

12.993

10.854

9.253

15.015

16.77

14.673

20.278

56

Subject 4

22.900

30.248

15.561

25.109

25.791

12.429

20.585

46.414

15.023

46.817

50

Subject 5

25.722

33.007

18.187

22.953

24.747

17.550

17.801

20.754

21.978

24.680

39

Subject 6

25.827

52.850

60.479

21.008

38.366

17.020

19.083

26.348

14.565

77.627

69

Subject 7

12.370

14.111

12.466

16.754

7.966

15.544

9.979

13.299

15.728

21.99

43

Subject 8

35.508

53.248

45.991

23.507

50.737

39.461

17.921

57.869

31.431

33.417

37

Subject 9

50.075

48.634

17.462

83.961

17.350

19.184

58.928

18.117

18.838

19.381

79

Subject 10

15.391

9.999

12.720

14.327

12.584

14.781

15.217

16.601

16.282

21.015

46

Raw Data for Treatment III (animation speed = 0.500 seconds)

 

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

# hplnks

Subject 1

27.830

35.230

26.720

17.001

23.398

18.328

27.811

37.707

26.514

49.136

47

Subject 2

34.584

28.978

32.118

24.928

22.848

19.976

15.975

37.268

19.352

30.256

38

Subject 3

16.952

37.041

29.184

16.462

22.123

14.026

18.113

20.444

18.813

40.322

48

Subject 4

22.549

35.198

23.367

22.53

25.298

15.578

19.297

33.050

25.155

36.939

37

Subject 5

36.048

38.712

30.114

24.455

23.113

18.318

24.005

24.335

18.447

25.282

43

Subject 6

17.470

34.970

15.425

20.122

15.098

14.292

19.295

18.729

14.416

40.675

48

Subject 7

22.172

160.930

27.715

24.404

54.459

18.599

25.676

31.549

27.851

62.302

55

Subject 8

40.093

36.855

21.709

25.189

24.369

19.428

18.654

25.788

23.748

24.879

40

Subject 9

12.437

13.866

15.644

16.217

13.419

10.533

10.329

12.408

12.379

11.796

37

Subject 10

21.242

24.239

18.437

26.527

23.100

18.34

12.996

24.757

31.519

26.461

44

Summarized Total Time for All Treaments

The table bellow shows summarized timing information, gathered from the 3 tables above.

In this table, subjects 1 to 10 performed Treatment 1, subjects 11-20 performed Treatment 2, and subjects 21 to 30 performed Treatment 3.

Subject

Tot Time

1

201.749

2

226.426

3

201.698

4

182.110

5

254.675

6

186.800

7

218.331

8

181.915

9

245.612

10

172.097

11

169.511

12

287.398

13

125.432

14

248.377

15

217.629

16

335.923

17

129.457

18

379.840

19

332.180

20

137.417

21

266.175

22

247.283

23

209.48

24

240.461

25

241.329

26

186.492

27

428.157

28

240.712

29

110.528

30

205.618

Raw Data for "Recall Question" in the Post-Experiment Survey

The table bellow shows the recall points earned by each subjects. Subjects 1 to 10 performed Treatment 1, subjects 11-20 performed Treatment 2, and subjects 21 to 30 performed Treatment 3.

The number of points is assigned as follows:

This gives a potential scale of values from -4 to 4, although in our trials there were no negative values observed.

Subject

Recall Pts

1

2

2

1

3

2

4

2

5

2

6

2

7

2

8

2

9

1

10

2

11

2

12

1

13

2

14

2

15

2

16

3

17

2

18

3

19

2

20

1

21

4

22

2

23

2

24

2

25

2

26

2

27

2

28

1

29

0

30

2

 

C.2 Subjective Evaluations

The two tables below correspond two the first two questions on the Pad++ software. These questions were answered by all the subjects. The full text of the questions can be found on the post experiment survey form. On both of these questions, 9 is the highest rating and 1 the lowest. The cells contain the number of subjects with each rating. In some cases subjects didn’t answer or circled N/A to indicate that they didn’t know enough to answer the question.

Q1. Is Pad++ easier to use than other browsers?

TRT 9 8 7 6 5 4 3 2 1
1 - 0.00 s 0 0 1 1 6 0 0 0 0
2 - 0.25 s 2 2 3 1 2 0 0 0 0
3 - 0.50 s 1 1 0 0 7 0 1 0 0

Q2. Is Pad++ better technology than existing browsers?

TRT 9 8 7 6 5 4 3 2 1
1 - 0.00 s 0 0 1 2 4 0 0 0 0
2 - 0.25 s 1 0 4 1 3 0 1 0 0
3 - 0.50 s 0 2 0 0 7 0 1 0 0

This final table rates the zooming feature of Pad++ on a 1 to 9 scale from very annoying to very pleasant to use. Again, the exact text for all the options can be found in Appendix B on the post experiment survey. Since only treatments 2 & 3 use the smooth animation of zooming, these questions were not asked of subjects who used treatment #1.

TRT 9 8 7 6 5 4 3 2 1
2 - 0.25 s 2 2 2 1 2 0 0 0 0
3 - 0.50 s 1 2 7 0 0 0 0 0 0